Motif ID: Vsx1_Uncx_Prrx2_Shox2_Noto
Z-value: 1.011





Transcription factors associated with Vsx1_Uncx_Prrx2_Shox2_Noto:
Gene Symbol | Entrez ID | Gene Name |
---|---|---|
Noto | ENSMUSG00000068302.7 | Noto |
Prrx2 | ENSMUSG00000039476.7 | Prrx2 |
Shox2 | ENSMUSG00000027833.10 | Shox2 |
Uncx | ENSMUSG00000029546.11 | Uncx |
Vsx1 | ENSMUSG00000033080.8 | Vsx1 |
Activity-expression correlation:
Gene Symbol | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Uncx | mm10_v2_chr5_+_139543889_139543904 | 0.88 | 3.8e-08 | Click! |
Shox2 | mm10_v2_chr3_-_66981279_66981318 | 0.29 | 1.8e-01 | Click! |
Prrx2 | mm10_v2_chr2_+_30845059_30845059 | -0.25 | 2.6e-01 | Click! |
Top targets:
Showing 1 to 20 of 200 entries
Gene overrepresentation in biological_process category:
Showing 1 to 20 of 131 entries
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 30.0 | GO:0007638 | mechanosensory behavior(GO:0007638) |
2.8 | 22.2 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.1 | 9.2 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.5 | 8.6 | GO:0021521 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
0.0 | 8.6 | GO:0018105 | peptidyl-serine phosphorylation(GO:0018105) |
0.4 | 7.8 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.4 | 6.2 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
1.5 | 6.0 | GO:0046552 | eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
0.5 | 6.0 | GO:0031017 | exocrine pancreas development(GO:0031017) |
0.7 | 5.9 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.8 | 5.6 | GO:0051798 | positive regulation of hair follicle development(GO:0051798) |
0.2 | 5.6 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
0.2 | 5.5 | GO:0003301 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.4 | 5.4 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.2 | 5.1 | GO:0008340 | determination of adult lifespan(GO:0008340) |
1.7 | 5.0 | GO:0002302 | CD8-positive, alpha-beta T cell differentiation involved in immune response(GO:0002302) |
0.0 | 4.9 | GO:0007605 | sensory perception of sound(GO:0007605) |
0.3 | 4.2 | GO:0007530 | sex determination(GO:0007530) |
0.1 | 4.1 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.1 | 4.0 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
Gene overrepresentation in cellular_component category:
Showing 1 to 20 of 61 entries
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 81.5 | GO:0005634 | nucleus(GO:0005634) |
0.0 | 14.0 | GO:0005794 | Golgi apparatus(GO:0005794) |
0.1 | 7.8 | GO:0000792 | heterochromatin(GO:0000792) |
0.2 | 6.2 | GO:0002102 | podosome(GO:0002102) |
0.2 | 6.0 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.0 | 5.3 | GO:0014069 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
0.1 | 5.1 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.0 | 3.2 | GO:0030426 | growth cone(GO:0030426) |
0.0 | 2.7 | GO:0016363 | nuclear matrix(GO:0016363) |
0.1 | 2.5 | GO:0031527 | filopodium membrane(GO:0031527) |
0.1 | 2.3 | GO:0032420 | stereocilium(GO:0032420) |
0.0 | 2.2 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 2.1 | GO:0043034 | costamere(GO:0043034) |
0.3 | 2.0 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.1 | 2.0 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.0 | 1.9 | GO:0070382 | exocytic vesicle(GO:0070382) |
0.1 | 1.5 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.1 | 1.4 | GO:0031045 | dense core granule(GO:0031045) |
0.4 | 1.3 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.3 | 1.3 | GO:0060187 | cell pole(GO:0060187) |
Gene overrepresentation in molecular_function category:
Showing 1 to 20 of 78 entries
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 47.9 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.0 | 29.4 | GO:0043565 | sequence-specific DNA binding(GO:0043565) |
2.6 | 17.9 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.2 | 7.3 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.0 | 6.8 | GO:0000287 | magnesium ion binding(GO:0000287) |
0.6 | 5.9 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.1 | 5.0 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.0 | 4.7 | GO:0003779 | actin binding(GO:0003779) |
0.5 | 4.5 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.0 | 4.1 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.3 | 3.7 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.3 | 3.6 | GO:0048185 | activin binding(GO:0048185) |
0.5 | 3.1 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.0 | 2.7 | GO:0003682 | chromatin binding(GO:0003682) |
0.0 | 2.6 | GO:0003924 | GTPase activity(GO:0003924) |
0.0 | 2.1 | GO:0004879 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
0.2 | 2.0 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.0 | 2.0 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.1 | 1.7 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.0 | 1.7 | GO:0005507 | copper ion binding(GO:0005507) |